Holen Sie sich die Stockscreener-App
37.74
0.34%
-0.13
Handel nachbörslich:
37.74
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
Supernus Pharmaceuticals, Inc. Enters into Lease Agreement for Approximately 136,016 Square Feet for its New Headquarters with Advent Key West, LLC - Marketscreener.com
Hennion & Walsh Asset Management Inc. Acquires 25,004 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Burney Co. Raises Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by JPMorgan Chase & Co. - Defense World
Despite the downward trend in earnings at Supernus Pharmaceuticals (NASDAQ:SUPN) the stock advances 3.1%, bringing five-year gains to 56% - Simply Wall St
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight - The Globe and Mail
SUPN (Supernus Pharmaceuticals) Intrinsic Value: DCF (FCF B - GuruFocus.com
(SUPN) Investment Report - Stock Traders Daily
Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 9.4% CAGR over the last five years - Yahoo Finance
Supernus Pharmaceuticals (NASDAQ:SUPN) Now Covered by Cantor Fitzgerald - Defense World
Supernus Pharmaceuticals (NASDAQ:SUPN) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Principal Financial Group Inc. - Defense World
Principal Financial Group Inc. Has $8.90 Million Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Franklin Resources Inc. Increases Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Where are the Opportunities in (SUPN) - Stock Traders Daily
Jane Street Group LLC Cuts Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Barclays PLC Grows Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Geode Capital Management LLC Has $46.22 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stock Holdings Lifted by Barclays PLC - Defense World
Geode Capital Management LLC Grows Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
HighTower Advisors LLC Takes $264,000 Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Stifel Financial Corp Increases Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Wellington Management Group LLP - MarketBeat
Fmr LLC Buys 8,499 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
(SUPN) Trading Signals - Stock Traders Daily
Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada - GlobeNewswire
Thinking about buying stock in BigBear.ai, Supernus Pharmaceuticals, Collegium Pharmaceutical, Duolingo, or Cryptoblox Technologies? - Marketscreener.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.50 Million Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
SUPN (Supernus Pharmaceuticals) 3-Year EPS without NRI Grow - GuruFocus.com
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Gap UpWhat's Next? - MarketBeat
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Simply Wall St
Ashford Capital Management Inc. Trims Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Quantbot Technologies LP Sells 21,601 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
28,185 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Bought by Systematic Financial Management LP - MarketBeat
How To Trade (SUPN) - Stock Traders Daily
Charles Schwab Investment Management Inc. Purchases 91,354 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
Charles Schwab Investment Management Inc. Acquires 91,354 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Supernus Pharmaceuticals executive sells shares worth $788,436 By Investing.com - Investing.com Canada
Supernus Pharmaceuticals executive sells shares worth $788,436 - Investing.com
Supernus Pharmaceuticals, Inc. Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD - Marketscreener.com
Intech Investment Management LLC Purchases 1,838 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World
PDT Partners LLC Buys Shares of 37,110 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference - The Manila Times
C21 Investments Inc (CXXI-CN) QuotePress Release - The Globe and Mail
Big Rock Brewery Inc (BR-T) QuotePress Release - The Globe and Mail
Supernus Pharmaceuticals CEO to Present at Piper Sandler Healthcare Conference | SUPN Stock News - StockTitan
Loomis Sayles & Co. L P Has $47.27 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Evertz Technologies Ltd (ET-T) QuotePress Release - The Globe and Mail
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
Segall Bryant & Hamill LLC Acquires New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
SUPN (Supernus Pharmaceuticals) Operating Margin % : 22.67% (As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Has $6.70 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
Pacer Advisors Inc. Buys 403,028 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat
0.94%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):